Key stats
About TIGER NASDAQ BIO
Expense ratio
0.30%
Home page
Inception date
Aug 26, 2014
ISIN
KR7203780002
The TIGER NASDAQ BIO ETF seeks investment results that corresponds generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (KRW).
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region